Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    24309022 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants
Conditions: Necrotizing Enterocolitis;   Very Low Birth Weight Infants
Interventions: Drug: Lactobacillus reuteri;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.